Lannett Inc Is Top STRONG BUY Upgrade At ValuEngine

For today’s bulletin, we take a look at our latest top-five STRONG BUY upgrade list and provide a link to download a FREE STOCK REPORT on Lannett Inc (LCI)

VALUATION WARNING: Overvalued stocks now make up 68.83% of our stocks assigned a valuation and 32.1% of those equities are calculated to be overvalued by 20% or more. Sixteen sectors are calculated to be overvalued.

To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE

For today’s edition of our upgrade list, we used our website’s advanced screening functions to search for UPGRADES to BUY or STRONG BUY with complete forecast and valuation data. They are presented by one-month forecast return. Lannett, Inc. (LCI) is our top-rated upgrade this week and it is a STRONG BUY. Our other picks are BUY-rated stocks.

Ticker Company Name Market Price Valuation Last 12-M Return 1-M Forecast Return 1-Yr Forecast Return P/E Ratio Sector Name
LCI LANNETT INC 21.05 -45.87% 14.90% 1.13% 13.61% 6.48 Medical
AIRM AIR METHODS CRP 43 5.67% 22.58% 0.53% 6.31% 17.67 Medical
AN AUTONATION INC 44.53 -18.98% -6.09% 0.52% 6.26% 10.93 Retail-Wholesale
JASO JA SOLAR HOLDGS 5.06 -33.02% -43.15% 0.51% 6.12% 3.35 Oils-Energy
CRL CHARLES RVR LAB 90 6.10% 27.35% 0.51% 6.12% 19.24 Medical

Lannett, Inc. (LCI) manufactures and distributes pharmaceutical products sold under generic names and historically has manufactured and distributed pharmaceutical products sold under its trade or brand names. In addition, the Company contract manufactures and private labels pharmaceutical products for other companies.

In their most recent earnings report, in February, the company reported a big increase in sales and noted that “Our outlook for the current fiscal year remains strong.  During the quarter, we received several product approvals and continued to make excellent progress.”

For the fiscal 2017 second quarter, net sales increased 35% to $170.9 million from $127.1 million for the second quarter of fiscal 2016.  Gross profit was $88.1 million compared with $71.6 million. Operating income was $34.3 million compared with $30.3 million.  Interest expense was $23.3 million compared with $11.8 million for the second quarter of fiscal 2016.  Net income attributable to Lannett was $8.2 million, or $0.22 per diluted share, compared with $13.5 million, or $0.36 per diluted share, for the fiscal 2016 second quarter.

The company is due to report earnings again at the beginning of May.

Analysts have a price target of @ $29.20/share on this stock with the consensus rating averaging out to a HOLD. That’s below our one-year forecast price of $23.91. The stock has bounced up quite a bit from its 52-week low–which was $16.75.

Below is today’s data on Lannett, Inc. (LCI):

VALUENGINE RECOMMENDATION: ValuEngine updated its recommendation from BUY to STRONG BUY for LANNETT INC on 2017-03-17. Based on the information we have gathered and our resulting research, we feel that LANNETT INC has the probability to OUTPERFORM average market performance for the next year. The company exhibits ATTRACTIVE P/E Ratio and Sharpe Ratio.

You can download a free copy of detailed report on Lannett, Inc. (LCI) from the link below.


ValuEngine Forecast
1-Month 21.29 1.13%
3-Month 21.04 -0.03%
6-Month 20.83 -1.04%
1-Year 23.91 13.61%
2-Year 18.93 -10.05%
3-Year 15.98 -24.08%
Valuation & Rankings
Valuation 45.87% undervalued Valuation Rank(?) 95
1-M Forecast Return 1.13% 1-M Forecast Return Rank 99
12-M Return 14.90% Momentum Rank(?) 52
Sharpe Ratio 0.56 Sharpe Ratio Rank(?) 80
5-Y Avg Annual Return 33.46% 5-Y Avg Annual Rtn Rank 96
Volatility 60.28% Volatility Rank(?) 28
Expected EPS Growth 8.21% EPS Growth Rank(?) 37
Market Cap (billions) 0.75 Size Rank 59
Trailing P/E Ratio 6.48 Trailing P/E Rank(?) 98
Forward P/E Ratio 5.99 Forward P/E Ratio Rank 96
PEG Ratio 0.79 PEG Ratio Rank 51
Price/Sales 1.17 Price/Sales Rank(?) 65
Market/Book 1.40 Market/Book Rank(?) 69
Beta 2.37 Beta Rank 8
Alpha -0.61 Alpha Rank 6


DOWNLOAD A FREE SAMPLE OF OUR LANNETT INC (LCI) REPORT BY CLICKING HERE is an Independent Research Provider (IRP), producing buy/hold/sell recommendations, target price, and valuations on over 5,000 US and Canadian equities every trading day.
Contact ValuEngine at (800) 381-5576 or
Visit for more information

ValuEngine Capital Management LLC is a Registered Investment Advisory (RIA) firm that trades client accounts using ValuENgine’s award-winning stock research.
Contact ValuEngine Capital at
Visit for more information

Leave a Comment